ArticleActa pharmacologica Sinica2023

SNS-023 sensitizes hepatocellular carcinoma to sorafenib by inducing degradation of cancer drivers SIX1 and RPS16.

Yuan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.